doi.org/10.1210/jc.86.11.5165, hdl.handle.net/1765/55133
Journal of Clinical Endocrinology and Metabolism
Department of Internal Medicine

Muller, A., Leebeek, F., Janssen, J., Lamberts, S., Hofland, L., & van der Lely, A.-J. (2001). Acute effect of pegvisomant on cardiovascular risk markers in healthy men: Implications for the pathogenesis of atherosclerosis in GH deficiency. Journal of Clinical Endocrinology and Metabolism, 86(11), 5165–5171. doi:10.1210/jc.86.11.5165